DNTH
Price
$21.83
Change
+$0.97 (+4.65%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
644.33M
LENZ
Price
$25.45
Change
+$0.27 (+1.07%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
692.47M
Ad is loading...

DNTH vs LENZ

Header iconDNTH vs LENZ Comparison
Open Charts DNTH vs LENZBanner chart's image
Dianthus Therapeutics
Price$21.83
Change+$0.97 (+4.65%)
Volume$2.7K
Capitalization644.33M
LENZ Therapeutics
Price$25.45
Change+$0.27 (+1.07%)
Volume$2.21K
Capitalization692.47M
DNTH vs LENZ Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. LENZ commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Buy and LENZ is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (DNTH: $21.77 vs. LENZ: $25.48)
Brand notoriety: DNTH and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 45% vs. LENZ: 53%
Market capitalization -- DNTH: $644.33M vs. LENZ: $692.47M
DNTH [@Biotechnology] is valued at $644.33M. LENZ’s [@Biotechnology] market capitalization is $692.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, LENZ is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 3 TA indicator(s) are bullish while LENZ’s TA Score has 5 bullish TA indicator(s).

  • DNTH’s TA Score: 3 bullish, 4 bearish.
  • LENZ’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а -2.29% price change this week, while LENZ (@Biotechnology) price change was +2.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.11%. For the same industry, the average monthly price growth was +1.05%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 09, 2023.

LENZ is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-1.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($692M) has a higher market cap than DNTH($644M). DNTH YTD gains are higher at: -0.138 vs. LENZ (-11.742). DNTH has more cash in the bank: 281M vs. LENZ (217M). DNTH has less debt than LENZ: DNTH (311K) vs LENZ (1.58M).
DNTHLENZDNTH / LENZ
Capitalization644M692M93%
EBITDA-82.47MN/A-
Gain YTD-0.138-11.7421%
P/E Ratio2.89N/A-
Revenue5.37MN/A-
Total Cash281M217M129%
Total Debt311K1.58M20%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHLENZ
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 26 days ago
79%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 24 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
58%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVIFX86.591.39
+1.63%
Thornburg Small/Mid Cap Core I
GRMRX28.010.15
+0.54%
Nationwide S&P 500 Index R
ENPSX35.64N/A
N/A
ProFunds UltraSector Energy Svc
FASGX27.98N/A
N/A
Fidelity Asset Manager 70%
AIBBX15.86N/A
N/A
Aristotle Small Cap Equity I-2

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with SLDB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+4.36%
SLDB - DNTH
42%
Loosely correlated
-0.30%
ANNX - DNTH
41%
Loosely correlated
-1.94%
PRME - DNTH
40%
Loosely correlated
+2.91%
IMNM - DNTH
39%
Loosely correlated
+12.41%
TRDA - DNTH
38%
Loosely correlated
+0.83%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with IVVD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+1.19%
IVVD - LENZ
36%
Loosely correlated
+1.22%
DNTH - LENZ
28%
Poorly correlated
+4.36%
TCRX - LENZ
26%
Poorly correlated
+3.20%
DSGN - LENZ
26%
Poorly correlated
+0.61%
OCGN - LENZ
25%
Poorly correlated
+3.97%
More